America's heroin crisis, Colombian heroin, and how we can improve Plan Colombia PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download America's heroin crisis, Colombian heroin, and how we can improve Plan Colombia PDF full book. Access full book title America's heroin crisis, Colombian heroin, and how we can improve Plan Colombia by United States. Congress. House. Committee on Government Reform. Download full books in PDF and EPUB format.
Author: United States. Congress. House. Committee on Government Reform
Publisher:
ISBN:
Category : Political Science
Languages : en
Pages : 236
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Government Reform
Publisher:
ISBN:
Category : Political Science
Languages : en
Pages : 236
Get Book Here
Book Description
Author: United States. Congress. House. Committee on International Relations
Publisher:
ISBN:
Category : Political Science
Languages : en
Pages : 88
Get Book Here
Book Description
Author: Dan Burton
Publisher:
ISBN: 9780756746018
Category : Political Science
Languages : en
Pages : 216
Get Book Here
Book Description
Witnesses: Barry Crane, Dep. Dir. for Supply Reduction, ONDCP; Paul Simons, Acting Assist. Sec. of State for Internat. Narcotics & Law Enforce.; Rogelio Guevara, Chief of Oper., DEA; Adam Isacson, Center for Internat. Policy; Felix Jimenez, ret. Special Agent in Charge, DEA, N.Y. Field Div., special Agent in charge, Transp. Security Admin., N.Y. Field Div.; Det. Tony Marcocci, Westmoreland County, PA, DA Office; Det. Sgt. Scott Pelletier, Portland, ME, Police Dept., head, Portland Police Dept.-Maine DEA., Heroin Task Force; Tom Carr, dir., Baltimore-Wash. High Intensity Drug Trafficking Area; & Mr. X, undercover narcotics Det., Howard County, MD, Police Dept. Also includes Letters, statements, etc. submitted for the record. Illustrated.
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Government Reform
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Government Reform
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: United States. Congress. House. Committee on International Relations
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 82
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Government Reform
Publisher:
ISBN:
Category : Political Science
Languages : en
Pages : 220
Get Book Here
Book Description
Author: United States. Congress. House. Committee on International Relations
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
